Michael Buerke

Prof. Michael Buerke


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2006 in Nutrition & Metabolism
Verified
Journal Article
Open access
ASAxel Schlitt
Axel Schlitt
SBStefan Blankenberg
Stefan Blankenberg
DYDaoguang Yan
Daoguang Yan
HGHans von Gizycki
Hans von Gizycki
MBMichael Buerke
Michael Buerke
XJXian-Cheng Jiang
Xian-Cheng Jiang
Background: Sphingomyelin (SM) is the major phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; thus, high levels of SM may promote atherogenesis. Methods: We investigated in a median follow up of 6.0 years the association of SM with the incidence of a combined endpoint (myocardial infarction and cardiovascular death) in stable and unstable patients, and its relation to other marker of atherosclerosis in 1,102 patients with angiographically documented CAD and 444 healthy controls. Results and discussion: Logistic regression analysis showed that SM categorized by median was associated with an elevated risk for CAD (HR 3.2, 95%CI 2.5–4.0, p < 0.05). SM levels were correlated with apoB (r = 0.34) and triglyceride levels (r = 0.31). In patients with stable angina (n = 614), SM categorized by median was not related to incidence of a combined endpoint (cardiovascular death and myocardial infarction) (p = 0.844 by Log-rank test). However, in patients with acute coronary syndrome (n = 488), elevated SM was related to the combined endpoint (p < 0.05 by Log-rank test), also in a multivariate Cox regression analysis including potential confounders (HR 1.8, 95%CI 1.0–3.3, p < 0.05). Conclusion: The results of our study reveal that 1) human plasma SM levels are a risk factor for CAD; 2) the pro-atherogenic property of plasma SM might be related to metabolism of apoB-containing or triglyceride-rich lipoproteins; and 3) plasma SM levels are a predictor for outcome of patients with acute coronary syndrome.

13 March 2011 in Herz
Verified
Journal Article
Closed access
PDF file
MBMichael Buerke
Michael Buerke
HLH. Lemm
H. Lemm
SDS. Dietz
S. Dietz
KWK. Werdan
K. Werdan

1 January 2007 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
MBMichael Buerke
Michael Buerke
MGMarkus Guckenbiehl
Markus Guckenbiehl
HSHansjörg Schwertz
Hansjörg Schwertz
UBUte Buerke
Ute Buerke
MHMichael Hilker
Michael Hilker
AWAndrew S. Weyrich
Andrew S. Weyrich

1 December 2014 in Atherosclerosis
Verified
Journal Article
Closed access
HFHang Fu
Hang Fu
FSFlorian Spieler
Florian Spieler
JGJulia Großmann
Julia Großmann
Dagmar RiemannDagmar Riemann
Dagmar Riemann
MLMarie Larisch
Marie Larisch
HLHarald Loppnow
Harald Loppnow

1 October 2006 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
MBMichael Buerke
Michael Buerke
HSHansjörg Schwertz
Hansjörg Schwertz
TLTina Längin
Tina Längin
UBUte Buerke
Ute Buerke
RPRoland Prondzinsky
Roland Prondzinsky
KWKarl Werdan
Karl Werdan

11 September 2007 in Circulation
Verified
Journal Article
Closed access
PDF file
MBMichael Buerke
Michael Buerke
DPDiethard Pruefer
Diethard Pruefer
DSDennis Sankat
Dennis Sankat
JCJustin M. Carter
Justin M. Carter
UBUte Buerke
Ute Buerke
KWKarl Werdan
Karl Werdan
Background—Reperfusion injury of ischemic myocardium has been attributed to neutrophil infiltration, inflammatory activation and cardiac necrosis/apoptosis. Serine protease inhibition with aprotinin is cardioprotective, but the mechanism is unknown.Methods and Results—We studied aprotinin in a rat model of myocardial ischemia for 20 minutes and reperfusion for 20 minutes, 8 hours or 24 hours. Aprotinin (20 000 IU/kg) given 5 minutes before reperfusion significantly reduced leukocyte accumulation (P<0.01), myocardial injury (determined by CK depletion,P<0.01) and myocyte apoptosis (P<0.05) compared with vehicle treated rats. Differential gene expression analysis showed myocardial ischemia plus reperfusion increased expression of proinflammatory genes like P-selectin, E-selectin, intercellular adhesion molecule, tumor necrosis factor-α, tumor necrosis factor-α receptor, interleukin-6, monocyte chemoattractant protein-1, p53, and Fas (CD59). Aprotinin before reperfusion suppressed expression of these inflammatory genes. Finally, differential protein expression analysis demonstrated increased intercellular adhesion molecule-1, tumor necrosis factor-α, and p53 after myocardial ischemia plus reperfusion, and this effect was diminished by aprotinin.Conclusions—We demonstrated myocardial ischemia plus reperfusion induced leukocyte accumulation, inflammation, gene expression, protein expression and finally tissue injury and showed aprotinin limiting reperfusion injury through each of these stages, even after 24 hours of reperfusion. This effect seems partly attributable to suppression of proinflammatory genes and leukocyte accumulation. This work casts further light on the complex signaling of ischemia and reperfusion.